Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04691375
Title A Study of PY314 in Subjects With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pionyr Immunotherapeutics Inc.

Her2-receptor negative breast cancer

cervical cancer

Advanced Solid Tumor

vaginal cancer

triple-receptor negative breast cancer

clear cell renal cell carcinoma

vulva cancer

ovarian cancer

colon cancer

lung adenocarcinoma

gastric adenocarcinoma

renal cell carcinoma

endometrial cancer


Pembrolizumab + PY314


Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.